Stocks · News reference

TD Cowen Maintains Hold on Humana, Raises Price Target to $370

Jul 31, 2026, 4:45 PMBenzinga Newsdesk

TD Cowen analyst Ryan Langston maintains Humana (NYSE:HUM) with a Hold and raises the price target from $350 to $370.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 25, 2026, 10:12 AMBenzinga Newsdesk
DaVita Enters Value-Based Care Agreement With Humana Medicare Advantage To Provide Care To Members With Chronic Kidney Disease Stages 3B–5
Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.As
Read original at benzinga
DVA HUM
BenzingaAug 14, 2026, 1:48 PMChandrima Sanyal
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs
Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
Read original at benzinga
CI CNC CVS ELV HUM
BenzingaAug 11, 2026, 8:28 AMRadhika Anilkumar Nadig
Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’
Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.
Read original at benzinga
CI CNC CVS ELV HUM
BenzingaAug 10, 2026, 6:30 PMBenzinga Newsdesk
JP Morgan Maintains Neutral on Humana, Raises Price Target to $393
JP Morgan analyst Lisa Gill maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $316 to $393.
Read original at benzinga
HUM